SchwabS.J., BullerG.L., McCannR.L., BollingerR.R., StickelD.L.. Prospective evaluation of a Dacron cuffed hemodialysis catheter for prolonged use.Am J Kidney Dis1988; 2: 166–9.
2.
MossA.H., VasilakisC., HolleyJ.L., FoulksC.J., PillaiK., McDowellD.E.. Use of silicone dual-lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients.Am J Kidney Dis1990; 16: 211–5.
DaeihaghP., JordanJ., ChenJ., RoccoM.. Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters.Am J Kidney Dis2000; 36: 75–79.
9.
DavisS.N., VermeulenL., BantonJ., SchwartzB.S., WilliamsE.C.. Activity and dosage of alteplase dilution for clearing occlusions of venous-access devices.Am J Health Syst Pharm2000; 57: 1039–45.
10.
HaireW.D., AtkinsonJ.B., StephensL.C., KotulakG.D.. Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: a double-blinded, randomized trial.Thromb Haemost1994; 72: 543–7.
11.
AtkinsonJ.B., BagnallH.A., GompertsE.. Investigational use of tissue plasminogen activator (t-PA) for occluded central venous catheters.J Parent Ent Nutr1990; 14: 310–1.
